Clinical Trials Directory

Trials / Unknown

UnknownNCT06310629

Oxygenation Efficacy of "Intrinseque Health" Non-Rebreathing Mask ("IHNRM")

Comparison of Oxygenation Efficacy of "Intrinseque Health" Non-Rebreathing Mask ("IHNRM") vs. High Flow Nasal Cannula (HFNC)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
China Medical University Hospital · Academic / Other
Sex
All
Age
3 Years
Healthy volunteers
Not accepted

Summary

Based on early bench-testing data and subsequent clinical case studies in the U.S., "Intrinseque Health" non-rebreathing mask (IHNRM) has delivered virtual elimination of air entrainment and preferential delivery of all available oxygen first into the alveolar spaces by sequential opening of valves in its controller manifold, even at oxygen flow as low as 10 LPM, patient can attain high alveolar oxygen concentration of 75% or more-far higher than attainable with face mask or nasal cannula. Numerous intubated patients emerging from the operating room require intensive critical care specialist supervision in order to transition to the regular care. This would enable higher patient turnover and more efficient utilization of hospital resources, if patient can be transited to the regular care earlier by using a device that supports high oxygenation. This will enable a faster, safe and smooth extubation in critical care, and earlier discharge from intensive care ward. This study is anticipated to take only around 2.5 hour per patient to complete. Patients meeting the inclusion and exclusion criteria of this study are placed on IHNRM and monitored until steady state of SpO2 of 95% or higher on 7-10 LPM has been maintained for at least 2 hours, when they can be discharged from the post-anesthesia care unit (PACU) to the regular care ward. The study is the parallel design study. 60 patients will be randomly selected to use the IHNRM, and 30 subjects will be placed on HFNC. Blood oxygen concentration (SpO2), respiratory rate, end tidal CO2 concentration (EtCO2), and vital sign will be recorded in the study. The endpoint of the study is to compare the effect after using between "IHNRM" and HFNC.

Conditions

Interventions

TypeNameDescription
DEVICEHigh Flow Nasal CannulaHigh Flow Nasal Cannula
DEVICE"Intrinseque Health" Non-Rebreathing Mask ("IHNRM")"Intrinseque Health" Non-Rebreathing Mask ("IHNRM")

Timeline

Start date
2024-02-22
Primary completion
2025-02-21
Completion
2025-05-21
First posted
2024-03-15
Last updated
2024-03-15

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06310629. Inclusion in this directory is not an endorsement.